Prognosis of Chronic Myeloid Leukemia: Studies from the Barcelona Group

References

• Tura S., Baccarani M., Corbelli G., the Italian Cooperative Study Group on Chronic Myeloid Leukaemia. Staging of chronic myeloid leukaemia. Br. J. Haematol. 1981; 47: 105–119
   PubMed Web of Science ®Google Scholar
• Gomez G. A., Sokal J. E., Walsh D. Prognostic features at diagnosis of chronic myelocytic leukemia. Cancer 1981; 47: 2470–2471
   PubMed Web of Science ®Google Scholar
• Cervantes F., Rozman C. A multivariate analysis of prognostic factors in chronic myeloid leukemia. Blood 1982; 60: 1298–1304
   PubMed Web of Science ®Google Scholar
• Kantarjian H. M., Smith T. L., Mc Credie K. B., et al. Clinical myelogenous leukemia: A multivariate analysis of patient characteristics and therapy with survival. Blood 1985; 66: 1326–1335
   PubMed Web of Science ®Google Scholar
• Sokal J. E., Cox E. B., Baccarani M., et al. Prognostic discrimination in “good-risk” chronic granulocytic leukemia. Blood 1984; 63: 789–799
   PubMed Web of Science ®Google Scholar
• Sokal J. E., Baccarani R., Tura S., et al. Prognostic discrimination among younger patients with chronic granulocytic leukemia: Relevance to bone marrow transplantation. Blood 1986; 66: 1352–1357
   Web of Science ®Google Scholar
• Sokal J. E., Gomez G. A., Baccarani M., et al. Prognostic significance of additional cytogenetic abnormalities at diagnosis of Philadelphia chromosome-positive chronic granulocytic leukemia. Blood 1988; 72: 294–298
   PubMed Web of Science ®Google Scholar
• Kantarjian H. M., Keating M. J., Smith T. L., Talpaz M., McCredie K. B. Proposal for a simple synthesis prognostic staging system in chronic myelogenous leukemia. Am. J. Med. 1990; 61: 1441–1446
   Google Scholar
• Gallin J. I., Jacobson R. J., Seligmann B. E., et al. A neutrophil marker reveals two groups of chronic myelogenous leukemia and its absence may be a marker of disease progression. Blood 1986; 68: 343–346
   PubMed Web of Science ®Google Scholar
• Todd M. B., Waldron J. A., Jennings T. A., et al. Loss of myeloid differentiation antigens precedes blastic transformation in chronic myelogenous leukemia. Blood 1987; 70: 122–131
   PubMed Web of Science ®Google Scholar
• Bednarek J. M., Knight R. D., Taylor G., Evans W. H. Progressive loss of phenotypic proteins in mature granulocytes before the onset of blast crisis in human chronic myelogenous leukemia. J. Nat. Cancer Inst. 1988; 80: 251–257
   PubMed Web of Science ®Google Scholar
• Malinen T., Palotie A., Pakkala S., Ruutu T., Jansson S. E. Acceleration of chronic myeloid leukemia correlates with calcitonin gene hypermethylation. Blood 1991; 77: 2435–2440
   PubMed Web of Science ®Google Scholar
• Feinstein E., Cimino G., Gale R. P., et al. p53 in chronic myelogenous leukemia in acute phase. Proc. Nat. Acad. Sci. USA 1991; 88: 6293–6297
   PubMed Web of Science ®Google Scholar
• Towatari M., Adachi K., Kato H., Saito H. Absence of the human retinoblastoma gene product in the megakaryoblastic crisis of chronic myelogenous leukemia. Blood 1991; 78: 2178–2181
   PubMed Web of Science ®Google Scholar
• Mills K. I., Benn P., Birnie G. D. Does the breakpoint cluster region (M-ber) influence the duration of the chronic phase in chronic myeloid leukemia? An analytical comparison of current literature. Blood 1991; 78: 1155–1161
   PubMed Web of Science ®Google Scholar
• Sokal J. E. Significance of Ph'-negative marrow cells in Ph'-positive chronic granulocytic leukemia. Blood 1980; 56: 1072–1076
   PubMed Web of Science ®Google Scholar
• Cervantes F., Rozman C., Ballesta F., Milá M. Prognostic significance of cytogenetical studies in chronic granulocytic leukaemia. Scand. J. Haematol. 1982; 28: 77–81
   PubMedGoogle Scholar
• Italian Cooperative Study Group on Chronic Myeloid Leukemia. Prospective confirmation of a prognostic classification of Ph+ chronic myeloid leukemia. Br. J. Haematol. 1988; 69: 463–466
   PubMed Web of Science ®Google Scholar
• Italian Cooperative Study Group on Chronic Myeloid Leukemia. Prospective confirmation of a prognostic classification of Ph+ chronic myeloid leukemia: the value of early evaluation of the course of the disease. Ann. Hematol. 1991; 63: 307–314
   PubMed Web of Science ®Google Scholar
• Lazzarino M., Morra E., Castello A., et al. Myelofibrosis in chronic granulocytic leukaemia: Clinicopathologic correlations and prognostic significance. Br. J. Haematol. 1986; 64: 227–240
   PubMed Web of Science ®Google Scholar
• Dekmezian R., Kantarjian H. M., Keating M. J., Talpaz M., McCredie K. B., Freireich E. J. The relevance of reticulin stain-measured fibrosis at diagnosis in chronic myelogenous leukemia. Cancer 1987; 59: 1738–1743
   Web of Science ®Google Scholar
• Thiele J., Kvasnicka H. M., Zancovich R., Fischer R., Diehl V. Parameters of predictive value in chronic myeloid leukemia. The prognostic impact of histopathological variables in a multivariate regression analysis. Leuk. Lymph. 1991; 4: 63–74
   PubMed Web of Science ®Google Scholar
• Cervantes F., Rozman C., Feliu E. Prognostic evaluation of initial bone marrow histopathological features in chronic granulocytic leukemia. Acta Haematol. 1989; 82: 12–15
   PubMed Web of Science ®Google Scholar
• Rozman M., Cervantes F., Rozman C. A study of the myeloid differentiation antigens of the peripheral blood neutrophil granulocytes in the different evolutive phases of chronic myeloid leukemia. Ann. Hematol. 1991; 62: 221–224
   PubMed Web of Science ®Google Scholar
• Kantarjian H. M., Keating M. J., Talpaz M., et al. Chronic myelogenous leukemia in blast crisis. Analysis of 242 patients. Am. J. Med. 1987; 83: 445–454
   PubMed Web of Science ®Google Scholar
• Cervantes F., Rozman M., Rosell J., Urbano-Ispizua A., Montserrat E., Rozman C. A study of prognostic factors in blast crisis of Philadelphia chromosome-positive chronic myelogenous leukaemia. Br. J. Haematol. 1990; 76: 27–32
   PubMed Web of Science ®Google Scholar
• Janossy G., Woodruff R. K., Peppard M. J., et al. Relation to “lymphoid” phenotype and response to chemotherapy incorporating vincristine-prednisone in the acute phase of Ph positive leukemia. Cancer 1979; 43: 426–434
   PubMed Web of Science ®Google Scholar
• Cervantes F., Ballesta F., Milá M., Rozman C. Cytogenetic studies in blast crisis of Ph-positive chronic granulocytic leukemia: results and prognostic evaluation in 52 patients. Cancer Gen. Cytogen. 1986; 21: 239–246
   PubMed Web of Science ®Google Scholar
• Canellos G. P., De Vita V. T., Whang-Peng J., Chabner B. A., Schein P. S., Young R. C. Chemotherapy of the blast phase of chronic granulocytic leukemia: Hypodiploidy and response to therapy. Blood 1976; 47: 1003–1009
   PubMed Web of Science ®Google Scholar